Revvity beat Q1 EPS and revenue estimates as 3% organic growth and portfolio execution offset margin pressure and China ...

Q1 2026 earnings call highlights: revenue +5.8%, EPS $0.97, BEES/D2C growth, FIFA catalyst, 4–8% EBITDA outlook—read now.

Q1 beat, China immunodiagnostics divestiture plan, and updated 2026 guidance on growth, margins, EPS—read now.

MetInfo CMS flaw CVE-2026-29014 exploited after April 7 patch, enabling remote code execution and targeting 2,000 instances.

The shipment included industrial pumps, spare parts, and oversized units measuring up to 8 metres in length and was moved ...

Q4 2026 Revenue Guidance -- Projected between $140 million and $160 million with expectations for continued negative non-GAAP ...

Q1 2026 Management view “We started the year strong in the first quarter and remain on track with our plans,” said CEO Anshul Thakral, highlighting “a Q1 book-to-bill of 1.15x and a trailing 12-month ...

DMALL is gaining momentum in Southeast Asia, leveraging its AI-driven retail platform to enhance operations and market ...

Threat actors are exploiting critical vulnerabilities in MetInfo CMS and Weaver E-cology for unauthenticated, remote code ...

ESET researchers have investigated an ongoing attack by the ScarCruft APT group that targets the Yanbian region via ...

Q1 2026 Management View "We delivered an excellent first quarter as a combined company" and "grew adjusted earnings per share by 20%" to $2.70, CEO Udit Batra said, while pointing to "double-digit ...

Lam Research (LRCX) reaches record $275.99 with 252% annual gain. Analysts boost targets to $340 as Q3 beats estimates ...